Insights

Innovative Diagnostic Technology XCellCure offers a cutting-edge multimarker cardiac panel, the AMiAware, which provides rapid, noninvasive assessment of heart attack risk through 13 novel biomarkers. This positions the company as a key partner for hospitals, emergency rooms, and clinics seeking advanced diagnostics to improve patient outcomes.

Focus on Preventative Care The company's emphasis on prognostics and prevention presents significant opportunities to collaborate with healthcare providers aiming to shift toward proactive cardiovascular management, reducing emergency admissions and long-term treatment costs.

Early Market Entry As a startup with an investigational device currently available for research and clinical use, XCellCure is positioned to establish early relationships with key cardiology centers and research institutions that could serve as advocates and early adopters for its products.

Expansion Potential With plans to release additional cardiac devices for various clinical settings, there is substantial sales potential across hospital departments, research labs, and point-of-care providers seeking innovative tools for cardiac monitoring and diagnostics.

Collaborative Opportunities Partnering with healthcare systems and biotech firms focused on cardiovascular disease could accelerate adoption of XCellCure’s solutions, especially given their focus on noninvasive, predictive diagnostics that align with current industry trends towards personalized and preventative medicine.

XCellCure Tech Stack

XCellCure uses 8 technology products and services including Microsoft 365, Video.js, jQuery, and more. Explore XCellCure's tech stack below.

  • Microsoft 365
    Email
  • Video.js
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Stripe
    Payment Processing
  • PHP
    Programming Languages
  • CodeIgniter
    Web Frameworks
  • Apache
    Web Servers
  • Twitter
    Widgets

Media & News

XCellCure's Email Address Formats

XCellCure uses at least 1 format(s):
XCellCure Email FormatsExamplePercentage
First.Last@xcellcure.comJohn.Doe@xcellcure.com
45%
FirstLast@xcellcure.comJohnDoe@xcellcure.com
5%
First.Last@xcellcure.comJohn.Doe@xcellcure.com
45%
FirstLast@xcellcure.comJohnDoe@xcellcure.com
5%

Frequently Asked Questions

Where is XCellCure's headquarters located?

Minus sign iconPlus sign icon
XCellCure's main headquarters is located at 1 Cityplace Drive St. Louis, Missouri 63131 United States. The company has employees across 1 continents, including North America.

What is XCellCure's phone number?

Minus sign iconPlus sign icon
You can contact XCellCure's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is XCellCure's official website and social media links?

Minus sign iconPlus sign icon
XCellCure's official website is xcellcure.com and has social profiles on LinkedIn.

What is XCellCure's SIC code NAICS code?

Minus sign iconPlus sign icon
XCellCure's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 33911 - Medical Equipment and Supplies Manufacturing.

How many employees does XCellCure have currently?

Minus sign iconPlus sign icon
As of February 2026, XCellCure has approximately 4 employees across 1 continents, including North America. Key team members include Cio: J. A.Vice President Research And Development: B. O.Vice President Product Development: G. A.. Explore XCellCure's employee directory with LeadIQ.

What industry does XCellCure belong to?

Minus sign iconPlus sign icon
XCellCure operates in the Medical Equipment Manufacturing industry.

What technology does XCellCure use?

Minus sign iconPlus sign icon
XCellCure's tech stack includes Microsoft 365Video.jsjQueryStripePHPCodeIgniterApacheTwitter.

What is XCellCure's email format?

Minus sign iconPlus sign icon
XCellCure's email format typically follows the pattern of First.Last@xcellcure.com. Find more XCellCure email formats with LeadIQ.

XCellCure

Medical Equipment ManufacturingMissouri, United States2-10 Employees

XCellCure is a startup biotechnology company focused on transforming modern cardiac care. We are excited to launch our first product the AMiAware, currently available as an investigational use only device to aid in the prevention of recurrent heart attack through patient-centered risk stratification utilizing 13 novel biomarkers. The motif of our clinical approach is to noninvasively diagnose and prognosticate patients experiencing acute coronary symptoms in order to assist in patient monitoring, aid therapeutic selection, prevent fatality, and reduce morbidity of cardiovascular disease.  We will be releasing a collection of cardiac devices for the research, clinical and point of care realms to supplement and improve current care and patient quality of life.

XCellCure’s novel multimarker cardiac panel has application for emergency room personnel to quickly assess the probability of an impending heart attack. Our first product, the AMiAware, allows users insight to key clinical evidence through a unique “Signature of Disease” that  guides physicians to make accurate and swift decisions, resulting in higher quality of care for patients with acute coronary syndromes. The AMiAware brings results for 13 known cardiac biomarkers into the diagnostic arsenal of cardiologists in a user-friendly platform giving doctors the decisive power to administer patient-centered therapy more rapidly than ever before.

Our aim is to revolutionize cardiac diagnostics through an emphasis on prognostics and prevention. The XCellCure AMiAware will give doctors the foresight to predict and stop a heart attack before it has even started.

By focusing on preventative medicine with a prognostic “Signature of Disease” approach, the AMiAware’s multiplexed proteomic biomarker panel can prevent patients from getting to the point at which precious heart tissue is already dying, saving hundreds of thousands of U.S. lives and millions of dollars each year.

Section iconCompany Overview

Headquarters
1 Cityplace Drive St. Louis, Missouri 63131 United States
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
33911 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    XCellCure's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    XCellCure's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.